CMAJ • February 14, 2006; 174 (4). doi:10.1503/cmaj.050880.
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendices
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, K. W.J.
Right arrow Articles by Frohlich, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, K. W.J.
Right arrow Articles by Frohlich, J. J.
Related Collections
Right arrow Other cardiovascular medicine
Right arrowRelated Article


Research

Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort

Kenny W.J. Lee, John S. Hill, Keith R. Walley and Jiri J. Frohlich

All of the authors are from the James Hogg iCAPTURE Centre of Cardiovascular and Pulmonary Research and, except for Keith Walley, the Healthy Heart Program, St. Paul's Hospital, Department of Pathology and Laboratory Medicine, and the University of British Columbia, Vancouver, B.C.

Correspondence to: Dr. John S. Hill, St. Paul's Hospital, Healthy Heart Program, 1081 Burrard St., Vancouver BC V6Z 1Y6; fax 604 806-8590; jshill{at}interchange.ubc.ca

Background: Although elevated levels of C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A protein (SAA) and total homocysteine (tHcy) have been associated with the increased likelihood of cardiovascular events, the relative or combined utility of these biomarkers in predicting atherosclerosis and death in an angiography cohort is unknown.

Methods: A cohort of 1117 consecutive patients (797 men and 320 women), referred to 2 Vancouver teaching hospitals for selective coronary angiography, was recruited between 1993 and 1995. Angiography results were obtained for 1019 patients. In 2004 we determined that of 1050 patients who could be traced, 231 had died, 95 of CAD-related causes. We compared the relative utility of baseline measurements of CRP, IL-6, SAA and tHcy as well as of lipids for predicting angiographic CAD and all-cause and CAD-related death.

Results: The risk of death increased across quartiles for CRP, IL-6, SAA and tHcy. When comparing the highest and lowest quartiles, the greatest hazard ratios were associated with IL-6 (2.57, 95% confidence interval [CI] 1.62–4.09) and tHcy (2.36, 95% CI 1.53–3.65). A Cox regression model containing all plasma biomarkers and traditional risk factors indicated that age, angiographic CAD and baseline plasma levels of IL-6 and tHcy remained independent predictors of CAD-related death, whereas age, sex, smoking, diabetes and apolipoprotein B levels were independent predictors of angiographic CAD. Kaplan–Meier survival curves indicated a utility in combining measures of CRP, SAA, IL-6 and tHcy for predicting risk of all-cause and CAD-related death.

Interpretation: A comparison of elevated levels of CRP, IL-6, SAA and tHcy with traditional CAD risk factors indicated that IL-6 and tHcy were the strongest independent biomarkers for CAD-related death. Elevated levels of multiple biomarkers were associated with an increasing rate of all-cause and CAD-related death.



Related Article

The association between elevated levels of inflammation biomarkers and coronary artery disease and death
Gordon D.O. Lowe
Can. Med. Assoc. J. 2006 174: 479-480. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am J EpidemiolHome page
N. Goldman, D. A. Glei, Y.-H. Lin, and M. Weinstein
Improving Mortality Prediction Using Biosocial Surveys
Am. J. Epidemiol., March 15, 2009; 169(6): 769 - 779.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. T. Antunes, A. Gagnon, M. L. Langille, and A. Sorisky
Thyroid-Stimulating Hormone Induces Interleukin-6 Release from Human Adipocytes through Activation of the Nuclear Factor-{kappa}B Pathway
Endocrinology, June 1, 2008; 149(6): 3062 - 3066.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Schmeck, W. Beermann, P. D. N'Guessan, A. C. Hocke, B. Opitz, J. Eitel, Q. T. Dinh, M. Witzenrath, M. Krull, N. Suttorp, et al.
Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Circ. Res., April 25, 2008; 102(8): 888 - 895.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. D.O. Lowe
The association between elevated levels of inflammation biomarkers and coronary artery disease and death.
Can. Med. Assoc. J., February 14, 2006; 174(4): 479 - 480.
[Full Text] [PDF]